PENTASA. 500 mg. 100 tablets

PENTASA. 500 mg. 100 tablets
€ 79.00
Add to Cart
Pentasa prolonged-release tablets are pale gray to pale brown, mottled, round tablets.
Pentasa prolonged release tablets removed chronic inflammation and bleeding in the colon and Crohn's disease.

PENTASA. 500 mg. 100 tablets

 
 
ACTION AND USE
Pentasa prolonged-release tablets are pale gray to pale brown, mottled, round tablets.
Pentasa prolonged release tablets removed chronic inflammation and bleeding in the colon and Crohn's disease.
Your doctor may prescribe medicine for another use. Always follow your doctor's instructions.
2. IMPORTANT INFORMATION TO READ BEFORE USING PENTASA RETARDTABLETTEN
Do not take Pentasa prolonged-release tablets if:
• you have severe liver disease or kidney.
• have a stomach ulcer or duodenum.
• have a bleeding tendency of the skin or mucous membranes in addition to bleeding from the bowel.
• you are allergic to mesalazine, salicylates, to one or
• more of the other ingredients in Pentasa prolonged-release tablets.

Special precautions:
Tell your doctor if:
• you are hypersensitive to sulfasalazine.
• your liver is not functioning normally.
• kidneys are not functioning normally.
• taking medicines for arthritis or pain (NSAIDs).
• taking medicines for autoimmune diseases (azathioprine).
• have impaired lung function (asthma).
• suddenly develop seizures, stomach pain, fever, prominent headache and rash. In such cases, you should immediately stop taking Pentasa.
It is important for your doctor to monitor you while using Pentasa ® prolonged-release tablets.
Taking Pentasa prolonged-release tablets with food and drink can dissolve Pentasa prolonged-release tablets in water or juice just before taking them.
Pregnancy and lactation
Ask your doctor or pharmacist before taking any medicine.
pregnancy
You should take Pentasa only advised by your doctor. Experience with Pentasa is limited.
breastfeeding
Do not take Pentasa, if you are breastfeeding. Experience with Pentasa is limited. Consult with your doctor.
Driving and using machines
Pentasa does not affect safety at work and the ability to drive safely.
Taking other medicines
There is an increased risk of blood disorders if used at the same time with Pentasa drugs for autoimmune diseases (azathioprine). Ask your doctor.
Always tell your doctor if you are taking or have recently taken any other medicines obtained without a prescription drugs purchased abroad, natural products, potent vitamins and minerals.
 

3. HOW TO TAKE PENTASA RETARDTABLETTEN?

dosage
Inflammatory bowel disease
adults:
The active form of the disease:
Dosage is individual. 9 to prolonged-release tablets (4,5 g mesalazine) daily in divided doses.
Maintenance dose: Dosage is individual. Generally, the dose is 4 to prolonged release tablets (2 g of mesalazine) divided doses.
children:
Pentasa should be administered to children only in special cases. Pentasa should not be given to children under 2 years of age. Ask your doctor.
Pentasa prolonged-release tablets should not be administered to children weighing less than 25 kg.
Children over 2 years of age:
Active form of the disease and the maintenance dose: Dosage is individual. The daily dose depends on the weight of the child. Always follow your doctor's instructions.
Normally the dosage is from 1/2 extended release tablet twice daily with 1 extended release tablet three times daily.
Crohn's disease
adults:
Dosage is individual. 9 to prolonged-release tablets (4,5 g mesalazine) daily in divided doses.
children:
Pentasa should be administered to children only in special cases. Pentasa ® should not be given to children under 2 years of age. Ask your doctor.
Pentasa prolonged-release tablets should not be administered to children weighing less than 25 kg.
Children over 2 years of age:
Dosage is individual. The daily dose depends on the weight of the child. Always follow your doctor's instructions.
Normally the dosage is from 1/2 extended release tablet twice daily with 1 extended release tablet three times daily.
Call your doctor if your disease (Crohn's disease) did not improve for 6 weeks or if they worsen with continued treatment.
You should not chew extended release tablets. You can split the tablet extended release or dissolve it in water or juice just before you take it. It is important to take regular prolonged-release tablets without skipping doses to achieve the best result.

 
Always follow your doctor's instructions. There are differences between different requirements. Your treatment may be modified or suspended only after consulting your doctor.

Making More Pentasa prolonged-release tablets than you should?
Experience with overdose is limited. Contact your doctor, pharmacist or emergency room if you use more Pentasa prolonged-release tablets than indicated in this information or than your doctor has prescribed, and you do not feel well.
Forget to take Pentasa prolonged-release tablets?
Do not use a double dose if you forget to take a dose of Pentasa prolonged-release tablets. Continue with normal dosage.
4. SIDE EFFECTS
Like all medicines Pentasa ® prolonged-release tablets can cause side effects.
Serious side effects
Rare side effects (seen in between 1 and 10 per 10,000 patients): Inflammation of the pericardium, chest pain, increased body temperature, breathing shortened. Call a physician or the emergency room.
Inflammation of the pancreas: marked pain in the stomach, fever. Call a physician or the emergency room. Very rare side effects (occurs in less than 1 in 10,000 patients):
Serious effects on the blood: bleeding, bruising impact, minor skin bleeding, fatigue, fever, persistent laryngitis or other forms of inflammation. Call a physician or the emergency room.
Hepatic effects: jaundice, fatigue, enlarged liver tests. Contact your doctor. Pneumonia. Contact your doctor.
Renal effects: fever, swelling of the legs, arms and face, back pain.
Dark urine. Renal failure. Contact your doctor. Serious hypersensitivity reactions with difficulty breathing and swelling of the tongue, lips and face. Immediately seek doctor or the emergency room.
Increased intracranial pressure: prominent headache, nausea, vomiting, slow pulse.
Fever, fatigue, pain and swelling of the joints, muscle pain and a rash due to connective tissue disease. [(Ask your doctor.
 
Aggravation of intestinal disease. Contact your doctor. Frivolous side effects
Common side effects (seen in between 1 and 10 patients in 100): Diarrhoea, stomach pain, nausea, vomiting, bloating, hives, rash, headache, fever.

Uncommon side effects (seen in between 1 and 10 per 1,000 patients):
Increased sensitivity of the skin to sunlight.
Rare side effects (seen in between 1 and 10 per 10,000 patients):
Dizziness.
Very rare side effects (occurs in less than 1 in 10,000 patients):
Hypersensitivity reactions, fever, abnormal sensitivity of hands and feet, transient hair loss. Pain in joints and muscles.
If you notice any side effects not listed in this information, please tell your doctor or pharmacist if these side effects are reported in Drug Agency and also to improve knowledge about side effects.
Tell your doctor or pharmacist if you have side effects that are persistent and disturbing. Some adverse reactions may require treatment.
5. STORAGE
Keep out of reach of children.
 
6. OTHER INFORMATION
Ingredients of Pentasa prolonged-release tablets 500 mg:
The active substance is mesalazine.
The other ingredients are povidone, ethylcellulose, magnesium stearate, talc, and microcrystalline cellulose.
 
 
€ 79.00
Add to Cart
Close